Seller record · Telehealth service

MEDGm

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S2, prescription gating: The order path reaches a checkout with no intake on it. The buy control on a product page opens a page headed that a prescription plan is approved, carrying a countdown on that approval and a purchase button, and the page holds no form and no medical question. 2 more criteria also fail; see the table below.

At a glance

MEDGmTelehealth service

5/8criteria passed

Price: Printed on its own pages before sign-up
Sells: compounded semaglutide injection, compounded tirzepatide injection, and 2 more
FDA letters: None on file

Partner link. The site earns a commission on care started through it. Funding

Visit MEDGm See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide injections and a compounded semaglutide tablet, on four price rungs each. It names four filling pharmacies with street addresses, and its order path reaches a checkout without asking a medical question.

Operating entity MEDGm, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	MEDGm's terms
S2	Prescription gating	FAIL	MEDGm's quiz page
S3	Pharmacy identification	PASS	MEDGm's terms
S4	Compounding disclosure	PASS	MEDGm's terms
S5	Analytical documentation	FAIL	MEDGm's website
S6	Business address	FAIL	MEDGm's contact page
S7	Price disclosure	PASS	MEDGm's compounded semaglutide injection product page
S8	Enforcement status	PASS	FDA's website

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSProviders licensed in the United States hold the prescribing decision through affiliated professional corporations, and the company states it does not practice medicine.Source: MEDGm's terms.

S2FAILThe order path reaches a checkout with no intake on it. The buy control on a product page opens a page headed that a prescription plan is approved, carrying a countdown on that approval and a purchase button, and the page holds no form and no medical question.Source: MEDGm's quiz page.

S3PASSFour filling pharmacies are named with street addresses and telephone numbers: RedRock Pharmacy, Health Warehouse, Precision Medicine and Triad Rx.Source: MEDGm's terms.

S4PASSThe terms state that compounded GLP-1 medications are not FDA-approved and have not been evaluated for safety, efficacy or quality, and name the compounding categories used.Source: MEDGm's terms.

S5FAILNo certificate, lot report or purity document is published or linked anywhere on the site.Source: MEDGm's website.

S6FAILNo street address is published. The contact page gives an email address and a telephone number and nothing else, and the terms print no operating address.Source: MEDGm's contact page.

S7PASSAll three products publish four priced rungs before intake, each stating both the total charged and the resulting monthly rate.Source: MEDGm's compounded semaglutide injection product page.

S8PASSNo FDA warning letter names the brand or the operating entity MEDGm, LLC, and no action has halted the business.Source: FDA's website.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, compounded tirzepatide injection, compounded semaglutide tablets, brand Wegovy, Zepbound and Ozempic through a membership.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Partner link. The site earns a commission on care started through it. Funding.

Visit MEDGm

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.